Biz and Tech Podcasts > Business > The Venari Podcast
Last Episode Date: No Date found.
Total Episodes: Not Available
Sean Tribull, our Hospitality & Leisure Lead, has launched Suite Talk, a new series for the Venari Podcast covering the latest insights on hospitality leadership. His second guest is Barbara Muckermann, CEO of Kempinski Hotels.
Sean Tribull, our Hospitality & Leisure Lead, has launched Suite Talk, a new series for the Venari Podcast covering the latest insights on hospitality leadership. His first guest is Orient Express Group CEO and Chief Strategy Officer at Accor, Gilda Perez-Alvarado.
In this episode of the HealthTech CEO series, Venari Partners Senior Consultant Cristian Owen speaks with Jens Noerterhaeuser, CEO & Co-founder of Kranus Health
Nuclear medicine is finally having its moment. Radiopharmaceuticals are poised to bring about a sea change in the treatment of cancer – though to make sure innovation in the space remains at the cutting edge, having the right talent is arguably the single most important aspect. It was this topic that led Ken Herrmann and Valentina Ambrosini, from Essen University Hospital and the University of Bologna respectively, to co-author an article for the European Journal of Nuclear Medicine and Molecular Imaging. This, in turn, caught the attention of our Senior Oncology R&D Consultant, Matthew Palmer. Matt invited Ken and Valentina to speak about their findings and their own insights on this topic on the Venari Podcast. So, what do the co-authors think about addressing the generation gap in nuclear medicine, and what are the implications of their research?
‘Employee engagement remains such an important part of the work that we do as HR leaders – and, really, as business leaders,’ says Amy Rodgers. She’s been Chief Human Resources Officer at PPC Flexible Packaging since November 2022, and has plenty of wisdom to share about managing talent in the packaging space. Tim Hartnell, Senior Consultant for our Sustainable Packaging practice, caught up with Amy on this episode of the Venari Podcast. Here are some of the key things we learned from their conversation!
‘I’ve always really loved the biotech space,’ says Sonya Montgomery. An experienced Chief Medical Officer (CMO) with a strong focus on genomic medicine for rare diseases, Sonya has over 20 years of experience developing drugs across the US, Canada, the UK, and the Netherlands. Having most recently worked at Evox Therapeutics, Sonya has also offered her services as an independent consultant for the past decade. Paula Doust Alba, CNS & Rare Disease Consultant for our Life Sciences team, was delighted to catch up with Sonya on the Venari Podcast to discuss Sonya’s career to date, her thoughts on building teams in the space, and prevalent trends within research and development.
Matthew Palmer, Senior Oncology Consultant for our life sciences practice, caught up with ARTBIO CEO Emanuele Ostuni for this episode of the Venari Podcast. You can read the transcript of the interview below for more on Emanuele’s career, what ARTBIO are working on, the challenges of being a CEO, and his thoughts on building teams for success.
It’s fair to say that Tiffany Olson has always kept herself busy. ‘When other girls were playing Barbie, I played store and I was making a profit at five years old,’ she notes. Tiffany took her entrepreneurial spirit and drive to the pharmaceutical industry, where an early taste of working life was enough to give her the bug: ‘Once I saw and experienced that patient impact, I was hooked on this industry. And I’ve stayed in it my entire career.’ Tiffany told Matt Palmer, Senior Oncology Consultant for our Life Sciences team, all about her career on this episode of the Venari Podcast’s Talking Radiopharma series.
Matthew Palmer, Senior Oncology Consultant for our Life Sciences team, caught up with Ian for the first episode of ‘Talking Radiopharma’, Matthew’s new series for the Venari Podcast. Read on for Ian’s thoughts on life as a CEO, ImaginAb’s R&D in theragnostics, and key challenges the company looks set to face going forward. Ian also has some fascinating insights on team building, the key skillsets he looks for in talent, and advice for budding scientists and developers in his nuclear medicine.
‘One of the things I’ve learned is you’re only as good as your team’. Michael Ferguson joined Abivax as Chief Commercial Officer earlier this year, since then they’ve IPO’d on Nasdaq (largest French Biotech IPO ever - $212m) and Michael has been building and shaping the commercial strategy and team. We discuss all this and more in the next episode of The Venari Podcast – have a listen!
Discover new partners and
collaboration opportunities —right in your inbox.
Get notified about new partnerships